KLRS Kalaris Therapeutics, Inc.

NASDAQ

$2.92

Kalaris Therapeutics, Inc. (KLRS) Earnings News

Earnings press releases, previews and reviews for Kalaris Therapeutics, Inc. (KLRS), newest first.

Tuesday August 11, 2026 8:00 AM ET

Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates

Tuesday May 12, 2026 8:00 AM ET

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates